These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24593290)

  • 1. Synthesis and evaluation of hydroxycamptothecin-encapsulated chitosan nanospheres for the treatment of liver cancer.
    Han J; Hou ZQ; Wang YG; Guo X
    Technol Cancer Res Treat; 2015 Feb; 14(1):111-7. PubMed ID: 24593290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular target delivery of 10-hydroxycamptothecin with solid lipid nanoparticles against multidrug resistance.
    Liu M; Chen D; Wang C; Chen X; Wen Z; Cao Y; He H
    J Drug Target; 2015; 23(9):800-5. PubMed ID: 25766079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG
    Yang L; Hong J; Di J; Guo Y; Han M; Liu M; Wang X
    Int J Nanomedicine; 2017; 12():3681-3695. PubMed ID: 28553107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycyrrhetinic Acid and TAT Peptide Modified Dual-functional Liposomes for Treatment of Hepatocellular Cancer.
    Huang S; Ren D; Wu X; Li M; Yu X; Nie X; Wang Y; Wang Y
    Curr Top Med Chem; 2020; 20(27):2493-2505. PubMed ID: 32703132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application.
    Wei W; Shi SJ; Liu J; Sun X; Ren K; Zhao D; Zhang XN; Zhang ZR; Gong T
    J Drug Target; 2010 Aug; 18(7):557-66. PubMed ID: 20131981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular delivery of 10-hydroxycamptothecin with targeted nanostructured lipid carriers against multidrug resistance.
    Liu M; Chen D; Mukerabigwi JF; Chen S; Zhang Y; Lei S; Luo S; Wen Z; Cao Y; Huang X; He H
    J Drug Target; 2016; 24(5):433-40. PubMed ID: 26422582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced tumor targeting and antitumor efficacy via hydroxycamptothecin-encapsulated folate-modified N-succinyl-N'-octyl chitosan micelles.
    Zhu H; Cao J; Cui S; Qian Z; Gu Y
    J Pharm Sci; 2013 Apr; 102(4):1318-32. PubMed ID: 23400693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced oral bioavailability of 10-hydroxycamptothecin through the use of poly (n-butyl cyanoacrylate) nanospheres.
    Jin X; Asghar S; Zhu X; Chen Z; Liu J; Li Y; Li H; Ping Q; Xiao Y
    Drug Dev Ind Pharm; 2017 Oct; 43(10):1637-1647. PubMed ID: 28481657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
    Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
    J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphiphilic Hybrid Dendritic-Linear Molecules as Nanocarriers for Shape-Dependent Antitumor Drug Delivery.
    Guo Y; Wang T; Zhao S; Han M; Dong Z; Wang X; Wang Y
    Mol Pharm; 2018 Jul; 15(7):2665-2673. PubMed ID: 29782803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyethyl starch conjugates for improving the stability, pharmacokinetic behavior and antitumor activity of 10-hydroxy camptothecin.
    Li G; Li Y; Tang Y; Zhang Y; Zhang Y; Yin T; Xu H; Cai C; Tang X
    Int J Pharm; 2014 Aug; 471(1-2):234-44. PubMed ID: 24861941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, characterization, biodistribution and antitumor efficacy of hydroxycamptothecin nanosuspensions.
    Han M; Liu X; Guo Y; Wang Y; Wang X
    Int J Pharm; 2013 Oct; 455(1-2):85-92. PubMed ID: 23928147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encapsulation of hydroxycamptothecin within porous and hollow poly(L-lactide-
    Zhuang S; Jin X; Cen L; Shao Y
    Biomater Sci; 2024 Jul; 12(14):3659-3671. PubMed ID: 38860438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, Characterization, and in vivo Evaluation of NK4-Conjugated Hydroxycamptothecin-Loaded Liposomes.
    Zhou T; Zhang W; Cheng D; Tang X; Feng J; Wu W
    Int J Nanomedicine; 2020; 15():2277-2286. PubMed ID: 32280220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
    Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
    J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced in vitro antitumor efficacy and strong anti-cell-migration activity of a hydroxycamptothecin-encapsulated magnetic nanovehicle.
    Ding GB; Liu HY; Lv YY; Liu XF; Guo Y; Sun CK; Xu L
    Chemistry; 2012 Oct; 18(44):14037-46. PubMed ID: 22996598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine-10-hydroxy camptothecine-loaded lipid microsphere for the synergistic treatment of liver cancer by inhibiting topoisomerase and HIF-1α.
    Qi Y; Liu G
    Drug Deliv; 2021 Dec; 28(1):171-182. PubMed ID: 33427515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of dual-sensitive nanogels based on chitosan and N-isopropylacrylamide and its intelligent drug delivery of 10-hydroxycamptothecine.
    Wang Y; Wang J; Xu H; Ge L; Zhu J
    Drug Deliv; 2015; 22(6):803-13. PubMed ID: 24512347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel multifunctional poly(amidoamine) dendrimeric delivery system with superior encapsulation capacity for targeted delivery of the chemotherapy drug 10-hydroxycamptothecin.
    Kong X; Yu K; Yu M; Feng Y; Wang J; Li M; Chen Z; He M; Guo R; Tian R; Li Y; Wu W; Hong Z
    Int J Pharm; 2014 Apr; 465(1-2):378-87. PubMed ID: 24530519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice.
    Zhang L; Yang M; Wang Q; Li Y; Guo R; Jiang X; Yang C; Liu B
    J Control Release; 2007 Jun; 119(2):153-62. PubMed ID: 17400320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.